HUP9904616A2 - Meiózist befolyásoló holesztánszármazékok - Google Patents

Meiózist befolyásoló holesztánszármazékok

Info

Publication number
HUP9904616A2
HUP9904616A2 HU9904616A HUP9904616A HUP9904616A2 HU P9904616 A2 HUP9904616 A2 HU P9904616A2 HU 9904616 A HU9904616 A HU 9904616A HU P9904616 A HUP9904616 A HU P9904616A HU P9904616 A2 HUP9904616 A2 HU P9904616A2
Authority
HU
Hungary
Prior art keywords
cholestane
derivatives
meiosis regulating
meiosis
regulating
Prior art date
Application number
HU9904616A
Other languages
English (en)
Inventor
Peter Faarup
Christian Grondahl
Frederik Christian Gronvald
Anthony Murray
Jan Lund Ottesen
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of HUP9904616A2 publication Critical patent/HUP9904616A2/hu
Publication of HUP9904616A3 publication Critical patent/HUP9904616A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • General Induction Heating (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bizőnyős (I) általánős képletű vegyületek, melyek szerkezetilegrőkőnők, példáűl a bikaheréből vagy hűmán tüszőnedvből extrahálhatótermészetes vegyületekkel, felhasználhatók őőciták és hímivarúcsírasejtek meiózisának befőlyásőlására. ŕ
HU9904616A 1996-12-20 1997-12-19 Meiosis regulating cholestane-derivatives HUP9904616A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK147896 1996-12-20
US4148897P 1997-02-11 1997-02-11
PCT/DK1997/000584 WO1998028323A1 (en) 1996-12-20 1997-12-19 Meiosis regulating compounds

Publications (2)

Publication Number Publication Date
HUP9904616A2 true HUP9904616A2 (hu) 2000-06-28
HUP9904616A3 HUP9904616A3 (en) 2001-02-28

Family

ID=26065809

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904616A HUP9904616A3 (en) 1996-12-20 1997-12-19 Meiosis regulating cholestane-derivatives

Country Status (12)

Country Link
US (3) US6486145B2 (hu)
EP (1) EP0946584B1 (hu)
JP (1) JP2001506656A (hu)
KR (1) KR20000069616A (hu)
AT (1) ATE238339T1 (hu)
AU (1) AU746878B2 (hu)
CA (1) CA2275683A1 (hu)
DE (1) DE69721304T2 (hu)
HU (1) HUP9904616A3 (hu)
IL (1) IL130249A0 (hu)
NO (1) NO313144B1 (hu)
WO (1) WO1998028323A1 (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030004148A1 (en) * 1994-06-23 2003-01-02 Byskov Anne G. Regulation of meiosis
IL139241A0 (en) 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
AU3701199A (en) * 1998-05-13 1999-11-29 Novo Nordisk A/S Meiosis regulating compounds
AU4498299A (en) * 1998-06-19 2000-01-10 Novo Nordisk A/S Meiosis regulating compounds
DE69903346T2 (de) * 1998-12-11 2003-01-30 Akzo Nobel Nv 22s-hydroxycholesta-8,14-dien derivate mit meiose regulierende aktivität
AU3279700A (en) * 1999-02-10 2000-08-29 Schering Aktiengesellschaft Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
CZ20012968A3 (cs) * 1999-02-24 2002-01-16 Novo Nordisk A/S Léčení neplodnosti
EP1156822B1 (en) 1999-02-24 2006-02-08 Novo Nordisk A/S Iin vitro method for synchronisation of oocyte maturation
WO2000051618A1 (en) * 1999-03-02 2000-09-08 Akzo Nobel N.V. (ANDROST-5-EN-17β-YL)ALKYL SULFOXIDES AND SULFONES AND THEIR USE FOR CONTROL OF FERTILITY
WO2000053618A1 (en) * 1999-03-09 2000-09-14 Akzo Nobel N.V. 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
US6902528B1 (en) * 1999-04-14 2005-06-07 Stereotaxis, Inc. Method and apparatus for magnetically controlling endoscopes in body lumens and cavities
EP1216059B1 (en) 1999-09-16 2005-10-19 Novo Nordisk A/S Composition for ivf
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
EP1257279A2 (en) * 2000-02-25 2002-11-20 Schering Aktiengesellschaft Improvement of implantation rate using ff-mas
JP2003529378A (ja) * 2000-04-06 2003-10-07 ノボ ノルディスク アクティーゼルスカブ 卵母細胞の細胞質および核成熟の体外成熟方法
US6988613B2 (en) 2001-02-06 2006-01-24 Novo Nordisk A/S Composition for IVF
EP1359881B1 (en) * 2001-02-06 2008-02-20 Novo Nordisk A/S Container with low oxygen content containing ff-mas
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
US8969543B2 (en) * 2003-04-03 2015-03-03 Bioneer Corporation SiRNA-hydrophilic polymer conjugates for intracellular delivery of siRNA and method thereof
US20080312673A1 (en) * 2007-06-05 2008-12-18 Viswanathan Raju R Method and apparatus for CTO crossing
EP3581563B1 (en) 2010-04-09 2023-06-28 The Research Foundation of the State University of New York Ship inhibitors and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1224738B (de) 1960-12-29 1966-09-15 Takeda Chemical Industries Ltd Verfahren zur Herstellung von Cholestan-3, 5, 6-triol-3-estern oder -3, 6-diestern soowie von deren Salzen
DE1183079B (de) 1961-11-27 1964-12-10 Vismara Francesco Spa Verfahren zur Herstellung von gesaettigten 4-Hydroxy-3-keto-5alpha-steroiden
CH470374A (de) 1965-09-24 1969-03-31 Hoffmann La Roche Verfahren zur Herstellung von Steroiden
DE1593492A1 (de) 1966-01-29 1970-07-16 Schering Ag 6-Ketosteroide aus 20-Formyl-6-keto-Steroide
IL38540A0 (en) 1971-01-18 1972-03-28 Dauten Sa Method for the extraction of insect moulting steroid hormones
ZA725157B (en) 1971-07-29 1973-04-25 Dauten Sa New steroid of insecticide action and process for its production
US4670190A (en) 1973-01-10 1987-06-02 Hesse Robert H 1-α-hydroxy vitamin D compounds and process for preparing same
FR2219943B1 (hu) 1973-03-02 1976-04-30 Eisai Co Ltd
IL41923A (en) 1973-04-01 1978-08-31 Yeda Res & Dev Preparation of hydroxylated derivatives of cholestanol and some such compounds
US3931403A (en) 1973-05-25 1976-01-06 Intellectual Property Development Corporation Antimicrobial compositions
US3887545A (en) 1973-11-12 1975-06-03 Hoffmann La Roche Synthesis of 1{60 -hydroxylated cholesterol derivatives
JPS5119752A (en) 1974-08-07 1976-02-17 Masayuki Ishikawa 1 arufua* 2 arufuaa jihidorokishikorekarushifuerooruno seiho
IL45897A (en) 1974-10-22 1978-12-17 Yeda Res & Dev Process for the preparation of 1 hydroxy-provitamin d3
JPS6039278B2 (ja) 1977-05-23 1985-09-05 中外製薬株式会社 ステロイド誘導体
DK162648C (da) 1979-02-15 1992-04-13 Teijin Ltd 3beta,25-dihydroxy-24-oxocholest-5-en-derivater og fremgangsmaade til fremstilling heraf
US4230626A (en) 1979-07-30 1980-10-28 G. D. Searle & Co. 25-Halocholest-5-ene-3β,22-diols and esters thereof
US4254045A (en) 1980-04-21 1981-03-03 Wisconsin Alumni Research Foundation 1α-Hydroxy-2β-fluorocholecalciferol
GB2089811B (en) 1980-09-22 1984-09-26 Wisconsin Alumni Res Found 23,25-dihydroxyvitamin d3
ATE15050T1 (de) 1981-04-29 1985-09-15 Hoffmann La Roche Verfahren zur herstellung von cholesterinderivaten und zwischenprodukte dafuer.
US4329295A (en) 1981-06-29 1982-05-11 G. D. Searle & Co. 24-Cyclopropylcholene-3β, 22-diols and esters thereof
US4348328A (en) 1981-11-09 1982-09-07 G.D. Searle & Co. 25-Substituted-5α-cholestane-3β,22S-diol
US4871727A (en) 1987-12-21 1989-10-03 Merck & Co, Inc. Anti-inflammatory and antidegenerative compounds isolated from L-681,512
JPH0749435B2 (ja) 1988-07-04 1995-05-31 帝人株式会社 １α，３β，２４−トリヒドロキシ−△▲上５▼−ステロイド類の製造方法
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
RU2188006C2 (ru) * 1995-03-06 2002-08-27 Ново Нордиск А/С Стимуляция мейоза

Also Published As

Publication number Publication date
EP0946584B1 (en) 2003-04-23
NO993009L (no) 1999-08-19
IL130249A0 (en) 2000-06-01
US20010005757A1 (en) 2001-06-28
DE69721304T2 (de) 2004-03-04
US20050004382A1 (en) 2005-01-06
WO1998028323A1 (en) 1998-07-02
US6486145B2 (en) 2002-11-26
ATE238339T1 (de) 2003-05-15
CA2275683A1 (en) 1998-07-02
EP0946584A1 (en) 1999-10-06
HUP9904616A3 (en) 2001-02-28
DE69721304D1 (de) 2003-05-28
JP2001506656A (ja) 2001-05-22
NO993009D0 (no) 1999-06-18
US20030032824A1 (en) 2003-02-13
AU746878B2 (en) 2002-05-02
US6759400B2 (en) 2004-07-06
NO313144B1 (no) 2002-08-19
KR20000069616A (ko) 2000-11-25
AU7878998A (en) 1998-07-17

Similar Documents

Publication Publication Date Title
HUP9904616A2 (hu) Meiózist befolyásoló holesztánszármazékok
MX9700174A (es) Derivados de esterol usados para la regulacion de la meiosis.
AR003441A1 (es) Compuestos para regular la meiosis y el uso de los mismos para preparar medicamentos.
MD1616F2 (en) Tricyclic compounds and method of inhibiting the tyrasin kinases receptors of the epidermal growth factor, pharmaceutical composition, methods of preventing the blastocites implantation and mammals treatment
DE69734605D1 (de) Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung
ATE305448T1 (de) Phenylalaninderivate als herbizide
NO930615D0 (no) Hypoglykemiske hydroksyurinstoffderivater
TR199801603T2 (xx) �ki par�a yivli k�l�f.
ES2128984B1 (es) Herbicidas a base de heteroariloxi-acetamidas para el empleo en el cultivo de arroz.
MX9704050A (es) P-amidinobencilamidas de dipeptido novedosas con radicales sulfonilo o aminosulfonilo en terminal n.
NO20005667D0 (no) Meioseregulerende forbindelser
KR970064396A (ko) 스트레스 완화용 사료
TR199901386T2 (en) �midazopiridazinler.
DK1343369T3 (da) Konservering af celler
DK0668852T3 (da) Substituerede orthoethenylphenyleddikesyrederivater
MX9801133A (es) Agente endoparasiticida a base de didepsipeptidos, nuevos didepsipeptidos y procedimiento para su produccion.
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання
BR9713762A (pt) Composto, uso dos mesmos, e, processo para regular a meiose em uma célula germinativa de mamìfero.
ATE148105T1 (de) Succinoylaminohydroxyäthylaminosulfamidsäureder vate und ihre verwendung als retrovirale proteasehemmer
TR199701011A2 (xx) 1-karba-(detia)-sefalosforin t�revleri.
DE59204447D1 (de) Cyclohexenonderivate als herbizide.
DK1194158T3 (da) Anvendelse af UK 114-proteiner til hæmning af organtransplantatafstödning
TR200100476T2 (tr) N-İkameli azabisikloheptan türevlerinin üretimleri ve kullanımları.
MD639G2 (ro) Mediu crioprotector pentru sperma de cocoş
SE8205849D0 (sv) Neue furobenzazepine, ihre herstellung und verwendung